Studied variables | After 2 months | Test of sig. | P value | |
---|---|---|---|---|
Group I (N=20) | Group II (N=20) | |||
PaO2 (mmHg) | ||||
Mean±SD | 65.5±7.63 | 63.9±4.05 | U | 0.092 |
Median | 66.0 | 64.5 | 1.68 | |
Range | 37.0–79.0 | 55.0–71.0 | ||
PaCO2 (mmHg) | ||||
Mean±SD | 43.6±7.03 | 50.7±4.72 | U | 0.001** |
Median | 44.0 | 50.0 | 4.08 | |
Range | 31.0–67.0 | 40.0–58.0 | ||
FVC (%) | ||||
Mean±SD | 77.2±15.0 | 80.5±4.93 | U | |
Median | 81.5 | 80.0 | 0.163 | 0.871 |
Range | 32.0–107.0 | 72.0–90.0 | ||
FEV1/FVC | ||||
Mean±SD | 60.2±10.9 | 57.6±7.72 | U | |
Median | 63.5 | 57.0 | 2.03 | 0.042* |
Range | 30.0–69.0 | 45.0–77.0 | ||
PEFR (%) | ||||
Mean±SD | 31.9±8.11 | 28.9±7.65 | U | |
Median | 32.0 | 26.5 | 01.35 | 0.174 |
Range | 20.0–52.0 | 20.0–42.0 | ||
mMRC dyspnea scale | ||||
Scale 2 | 6 (30.0) | 7 (35.0) | X2 | 0.942 |
Scale 3 | 12 (60.0) | 11 (55.0) | 0.1204 | |
Scale 4 | 2 (10.0) | 2 (10.0) |